Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.2B | 8.1B | 7.4B | 7.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 611M | -167M | 722M | 721M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.6B | 5.2B | 5.1B | 5.6B |
| Tax provision | 923M | 1.0B | 1.0B | 1.1B |
| Net income | 3.7B | 4.1B | 4.0B | 4.5B |
| Basic EPS | 0.0 | — | 0.0 | 0.0 |
| Diluted EPS | 0.0 | — | 0.0 | 0.0 |
| Basic average shares | 5.9B | — | 5.9B | 5.9B |
| Diluted average shares | 5.9B | — | 5.9B | 5.9B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |